Results of Combined Cataract and Glaucoma Surgery with Mitomycin C

Lee, Dong Yeon; Kim, Dong Min; Kim, Myung Hee; Ahn, Chung Sook

Abstract

To evaluate the results for intraocular pressure (IOP), visual acuity and postoperative complications, we conducted a retrospective review of the records of 29 consecutive cases who had combined cataract and glaucoma surgery with mitomycin C (0.2mg/ml) in patients with coexisting cataract and glaucoma. The mean follow-up period was 6.8 +/- 1.8 months. The mean preoperative lOP was 26.3 +/- 9.1mmHg(range, 11-44mmHg), which decreased by mean 12.1mmHg to a mean postoperative IOP of 14.2 +/- 3.4mmHg(range,7-22mmHg) as measured at the last follow-up. At the last follow-up, 21 eyes(72.4%) had IOPs of 21mmHg or less without glaucoma medications as complete sucess. The mean preoperative number of antiglaucoma medication was 2.4 +/- 1.0 (range, 1-4), which decrease to a mean number of antiglaucoma medication of 0.4 +/- 0.7 (range, 0-2) at the last follow-up. All patients were using fewer medications at last follow-up than preoperatively. Twenty two eyes (75.9%) had a best-corrected visual acuity of 0.5 or better at the last follow-up. Last follow-up best-corrected visual acuity was better than the preoperative best-corrected visual acuity for all patients. Six eyes (20.7%) had fibrinous uveitis as the most common postoperative complication, and other complications were hyphema, wound leak and cystoid macular edema etc. The glaucoma triple procedure with adjunctive mitomycin C(0.2mg/ml) appears to be a safe and effective surgical technique for treating patients with coexisting cataract and glaucoma.